Tenax Therapeutics
(TENX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 94,851 | 9,792 | 2,124 | 5,584 | 6,250 |
| Marketable Securities | N/A | N/A | N/A | N/A | 463 |
| Other current assets | 64 | 252 | 346 | 0 | 0 |
| TOTAL | $96,686 | $11,684 | $3,209 | $5,689 | $6,796 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 7 | 7 | 6 |
| Other Non-Current Assets | 0 | 1 | 189 | 296 | 67 |
| TOTAL | $N/A | $1 | $196 | $303 | $73 |
| Total Assets | $96,686 | $11,685 | $3,405 | $5,992 | $6,869 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,157 | 2,073 | 448 | 860 | 758 |
| Accrued Expenses | 1,536 | 1,013 | 775 | 704 | 1,241 |
| TOTAL | $4,693 | $3,587 | $1,848 | $1,564 | $2,119 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 64 | 184 | 124 |
| TOTAL | $N/A | $N/A | $64 | $184 | $124 |
| Total Liabilities | $4,693 | $3,587 | $1,912 | $1,748 | $2,243 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,970 | 1,958 | 280 | 16 | 9 |
| Common Shares | N/A | N/A | 0 | 3 | 1 |
| Retained earnings | -314,855 | -297,253 | -289,542 | -278,494 | -246,020 |
| TOTAL | $91,993 | $8,098 | $1,493 | $4,245 | $4,626 |
| Total Liabilities And Equity | $96,686 | $11,685 | $3,405 | $5,992 | $6,869 |